Systen Sequi, patch transdermique (emballage combiné)

7680547160288 CH-54716 Pflaster

Associated product:

SYSTEN Sequi patch mat sach 8 pce
Systen Sequi, patch transdermique (emballage combiné)
Systen Sequi, patch transdermique (emballage combiné)
1 / 2
google

Article details

Package size
8
Selling units
8
Measure
Pflaster
Galenic form
Pflaster
Galenic group
Pflaster/Transdermale Systeme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/09/2025
Patient information leaflet
Français
15/09/2025
Patient information leaflet
Italien
15/09/2025
Summary of Product Characteristics
Allemand
15/09/2025
Summary of Product Characteristics
Français
15/09/2025
Summary of Product Characteristics
Italien
15/09/2025

Detailed composition

Substance Quantity Type Category
II
3.1 MG Substance Wirkstoff (Principe actif)
I
3.1 MG Substance Wirkstoff (Principe actif)
II
3.2 MG Substance WIZUS
I
3.2 MG Substance WIZUS
II
11.2 MG Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HPFLA
II
- Substance HPFLA
I
- Substance HNIDK
II
- Substance HNIDK

Reimbursement information

Public price
CHF 17.55
Specialties list
Yes
Generic
No
SL addition date: 15/03/1999

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
54716
Drug name
Systen Sequi, patch transdermique (emballage combiné)
Galenic form
TRAP
ATC Code
G03FA01
Authorization status
Z
Dispensing category
B
First authorization
24/12/1998
Authorization expiration date
31/12/9999
IT Number
07.08.6.
Domain
Human medicine
Field of application
Oestrogen-Gestagen-Substitutionstherapie nach der Menopause

Package details

Description (FR)
SYSTEN Sequi patch mat sach 8 pce
Description (DE)
SYSTEN Sequi Matrixpfl Btl 8 Stk
Market launch
24/12/1998
Narcotic (BTM)
No

Other package sizes (1)

SYSTEN SEQUI patch mat 24 pce
None None
GTIN: 7680547160363
Not in V1